NIH-funded research R15 grant

Analyzing specific forms of the Akt protein in live cells

Official title: Live Cell Isoform-specific Akt Analyses

Funded at Texas Tech University · NIH-10796490 · Data updated 2026-11-12

This study is exploring new ways to see how two similar proteins, Akt1 and Akt2, work in living cells, which could help us understand their roles in diseases like diabetes, and it also gives undergraduate students a chance to learn about biomedical research.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionTexas Tech University
NIH-funded
Lab location1 site (Lubbock, United States)
Project startSeptember 10, 2023
Project endAugust 31, 2026
Funding year2023
Award (this year)$475,279
NIH project number1R15GM147858-01A1
Project IDNIH-10796490 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with conditions influenced by Akt protein activity, particularly those with metabolic disorders like diabetes.

Less likely to help

Patients with conditions unrelated to Akt protein function or those not experiencing metabolic disorders may not benefit from this research.

What this research studies

This research focuses on developing innovative methods to analyze the activity of two closely related proteins, Akt1 and Akt2, in live cells. By using advanced fluorescent techniques, the project aims to quantify the specific activities of these proteins, which play crucial roles in various biological processes and diseases, including diabetes. The research combines established chemical-genetic methods with nanoparticle technology to enable precise tagging of protein substrates, allowing for a clearer understanding of how these proteins function differently despite their similarities. This work not only advances scientific knowledge but also supports the training of undergraduate researchers in the biomedical field.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and treatment options for diseases related to Akt protein dysfunction, such as diabetes.

How similar studies have gone: Previous research has shown promise in using similar live-cell analysis techniques to study protein functions, indicating potential for success in this novel approach.

Where this research is happening

  • Texas Tech University
    Lubbock, United States
    Active

Researchers

  • Principal investigator: Wang, Degeng — Texas Tech University
  • Study coordinator: Wang, Degeng

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.